ADME Pharmacogenomics in Drug Development

作者: Liangfu Chen , Joseph W. Polli

DOI: 10.1002/9781118353240.CH2

关键词:

摘要:

参考文章(125)
John Deeken, The Affymetrix DMET platform and pharmacogenetics in drug development. Current Opinion in Molecular Therapeutics. ,vol. 11, pp. 260- 268 ,(2009)
Alison M. Goate, Jennifer M. Kwon, The candidate gene approach. Alcohol Research & Health. ,vol. 24, pp. 164- 168 ,(2000)
Peter Eichhammer, Berthold Langguth, Rainer Wiegand, Alexander Kharraz, Ulrich Frick, Göran Hajak, Allelic variation in the serotonin transporter promoter affects neuromodulatory effects of a selective serotonin transporter reuptake inhibitor (SSRI). Psychopharmacology. ,vol. 166, pp. 294- 297 ,(2003) , 10.1007/S00213-002-1370-1
SLCO1B1 variants and statin-induced myopathy--a genomewide study The New England Journal of Medicine. ,vol. 359, pp. 789- 799 ,(2008) , 10.1056/NEJMOA0801936
Laila Nurmohamed, Facundo Garcia-Bournissen, Russell J. Buono, Michael W. Shannon, Yaron Finkelstein, Predisposition to epilepsy-Does the ABCB1 gene play a role? Epilepsia. ,vol. 51, pp. 1882- 1885 ,(2010) , 10.1111/J.1528-1167.2010.02588.X
U A Meyer, S Kimura, R C Skoda, F J Gonzalez, M Umeno, The human debrisoquine 4-hydroxylase (CYP2D) locus: sequence and identification of the polymorphic CYP2D6 gene, a related gene, and a pseudogene. American Journal of Human Genetics. ,vol. 45, pp. 889- 904 ,(1989)
Sanjay M. Sisodiya, David B. Goldstein, Drug resistance in epilepsy: More twists in the tale Epilepsia. ,vol. 48, pp. 2369- 2370 ,(2007) , 10.1111/J.1528-1167.2007.01260_1.X
Richard H. Ho, Rommel G. Tirona, Brenda F. Leake, Hartmut Glaeser, Wooin Lee, Christopher J. Lemke, Yi Wang, Richard B. Kim, Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and Pharmacogenetics Gastroenterology. ,vol. 130, pp. 1793- 1806 ,(2006) , 10.1053/J.GASTRO.2006.02.034
Tristan M Sissung, Bevin C English, David Venzon, William D Figg, John F Deeken, Clinical pharmacology and pharmacogenetics in a genomics era: the DMET platform. Pharmacogenomics. ,vol. 11, pp. 89- 103 ,(2010) , 10.2217/PGS.09.154